HCWB HCW Biologics Inc. - Common Stock
$2,26
Cena · Sie 19, 2026
Dane fundamentalne na dzień Sie 14, 2026
Zakres 52 tyg.
$0–$7
28% of range
Ocena Analityków
BUY
7 analysts
Cena Docelowa
$30
+1227% upside
P/E (TTM)
-0.1
ROE
-586.8%
Marża Zysku Netto
-14677.1%
HCWB Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.26
Kapitalizacja Rynkowa
—
P/E (TTM)
-0.1
EPS (TTM)
$-10.63
Przychody (TTM)
$54.2K
Stopa dywidendy
—
ROE
-586.8%
D/E Dług/Kapitał
2.5
Zakres 52 tyg.
$0 – $7
HCWB Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$54.2K
2020-12-31
→
2025-12-31
EPS
$-10.63
2021-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-13M
2021-12-31
→
2025-12-31
Marże
-14677.1%
2022-12-31
→
2025-12-31
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
HCWB
Mediana porównawcza
P/E (TTM)
-0.1
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
HCWB
Mediana porównawcza
Gross Margin (Marża brutto)
20.0%
66.5%
Operating Margin (Marża Operacyjna)
-24270.7%
—
Net Profit Margin (Marża Zysku Netto)
-14677.1%
-313.2%
ROA
-29.1%
-105.1%
ROE
-586.8%
-142.1%
ROIC
-137.5%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
HCWB
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
2.5
0.0
Current Ratio (Wskaźnik bieżący)
0.1
1.6
Quick Ratio (Wskaźnik Szybkości)
0.1
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
HCWB
Mediana porównawcza
Revenue YoY (Przychody R/R)
-97.9%
—
Revenue CAGR 3Y (Przychody CAGR 3L)
-79.9%
—
Revenue CAGR 5Y (Przychody CAGR 5L)
-57.9%
—
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
HCWB
Mediana porównawcza
HCWB Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
7 analityków
- Mocne kupno 2 28,6%
- Kup 4 57,1%
- Trzymaj 1 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-08-16
Niski
$30.00
Wysoki
$30.00
Średni cel
$30.00
+1227,4%
Średnia cel
$30.00
+1227,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-6.2%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 31 marca 2026 | $2.22 | $-2.69 | 4.9% |
| 31 grudnia 2025 | $-18.36 | $-5.14 | -13.2% |
| 30 września 2025 | $-12.12 | $-14.08 | 2.0% |
| 30 czerwca 2025 | $-6.48 | $11.02 | -17.5% |
| 31 grudnia 2024 | $-3.20 | $3.67 | -6.9% |
| 31 grudnia 2023 | $-12.00 | $-5.71 | -6.3% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| HCWB | — | -0.1 | -97.9% | -14677.1% | -586.8% | 20.0% |
| TCRT | — | -1.5 | -50.0% | — | — | — |
| MBIO | — | -2.5 | — | — | -30.9% | — |
| APVO | $9M | -0.1 | — | — | -217.2% | — |
| MBRX | — | — | — | — | — | — |
| REVB | — | — | — | — | — | — |
| SILO | $5M | -0.7 | 0.00% | -5863.5% | -75.3% | 38.6% |
| VIVS | $4M | -0.3 | -9.0% | -10567.2% | -294.8% | — |
| CRIS | $13M | -1.7 | -13.4% | -80.3% | 177.9% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $54.2K | $3M | $3M | $7M | $0 | $4M | |
| Cost of Revenue | $43.4K | $2M | $2M | $4M | $0 | · | |
| Gross Profit | $10.8K | $959.4K | $560.4K | $3M | $0 | · | |
| R&D Expense | $5M | $6M | $8M | $9M | $8M | $7M | |
| SG&A Expense | $8M | $7M | $7M | $8M | $5M | $3M | |
| Operating Expenses | $13M | $30M | $26M | $18M | $13M | $10M | |
| Operating Income | $-13M | $-29M | $-26M | $-15M | $-13M | $-6M | |
| Interest Expense | $845.1K | $654.3K | $283.0K | $126.7K | $0 | · | |
| Other Non-op | $0 | $-1M | · | · | · | · | |
| Pretax Income | $-8M | $-30M | $-25M | $-15M | $-13M | $-6M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-30M | $-25M | $-15M | $-13M | $-6M | |
| EPS (Basic) | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 | · | |
| EPS (Diluted) | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 | · | |
| Shares (Basic) | 2,097,701 | 969,825 | 35,929,446 | 35,822,249 | 18,770,935 | · | |
| Shares (Diluted) | 2,097,701 | 969,825 | 35,929,446 | 35,822,249 | 18,770,935 | · | |
| EBITDA | $-12M | $-28M | $-25M | $-14M | $-13M | · |
Bilans 25
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $5M | $4M | $22M | $12M | $8M | |
| Short-term Investments | $0 | $0 | $0 | $10M | $25M | · | |
| Receivables | $32.2K | $582.2K | $2M | $417.7K | $133.0K | $2M | |
| Prepaid Expense | $222.2K | $328.2K | $1M | $1M | $2M | $538.3K | |
| Other Current Assets | $77.6K | $113.5K | $230.9K | $196.0K | $1M | $654.5K | |
| Current Assets | $2M | $6M | $6M | $34M | $40M | $12M | |
| PP&E (Net) | $21M | $23M | $20M | $11M | $1M | $2M | |
| PP&E (Gross) | $25M | $27M | $23M | $13M | $3M | $3M | |
| Accum. Depreciation | $4M | $4M | $3M | $2M | $2M | $1M | |
| Other Non-current Assets | $28.5K | $28.5K | $56.5K | $333.9K | $393.3K | $34.2K | |
| Total Assets | $25M | $30M | $29M | $47M | $54M | $15M | |
| Accounts Payable | $13M | $22M | $6M | $1M | $223.7K | $155.3K | |
| Short-term Debt | $7M | $6M | $0 | · | · | · | |
| Current Liabilities | $21M | $30M | $9M | $3M | $2M | $1M | |
| Capital Leases | · | · | · | $14.3K | · | · | |
| Deferred Tax | $24.9K | $40.9K | $146.9K | $0 | · | · | |
| Other Non-current Liabilities | $692.5K | · | · | · | · | · | |
| Total Liabilities | $22M | $37M | $15M | $9M | $2M | · | |
| Long-term Debt | $0 | $7M | $6M | $6M | $0 | · | |
| Total Debt | $7M | $6M | $119.4K | $38M | · | · | |
| Common Stock | $55 | $111 | $3.6K | $3.6K | $3.6K | · | |
| Paid-in Capital | $111M | $94M | $84M | $83M | $82M | $0 | |
| Retained Earnings | $-109M | $-101M | $-71M | $-46M | $-31M | $-17M | |
| Stockholders' Equity | $3M | $-7M | $13M | $37M | $51M | $-17M | |
| Liabilities + Equity | $25M | $30M | $29M | $47M | $54M | $15M |
Przepływy pieniężne 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $1M | $1M | $1M | $717.9K | $543.6K | $572.9K | |
| Stock-based Comp | $768.6K | $1M | $1M | $1M | $361.0K | $21.9K | |
| Other Non-cash | $-7M | $14M | $341.2K | $3M | $982.2K | · | |
| Operating Cash Flow | $-13M | $-14M | $-23M | $-10M | $-11M | $-10M | |
| CapEx | $0 | $261.6K | $6M | $10M | $47.3K | $186.7K | |
| Investing Cash Flow | $0 | $-261.6K | $4M | $15M | $-35M | $-186.7K | |
| Debt Issued | · | · | · | · | $0 | $563.6K | |
| Net Debt Issued | · | · | · | · | $0 | · | |
| Stock Issued | $5M | $6M | $23.7K | $15.8K | $29.5K | $9.9K | |
| Net Stock Activity | $5M | $6M | $23.7K | $15.8K | $29.5K | · | |
| Financing Cash Flow | $11M | $16M | $-14.5K | $6M | $49M | $12M | |
| Net Change in Cash | $-3M | $1M | $-19M | $11M | $3M | $1M | |
| Free Cash Flow | $-13M | $-14M | $-29M | $-21M | $-11M | · | |
| Levered FCF | $-14M | $-15M | · | $-21M | · | · |
Rentowność 8
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 20.0% | 37.4% | 19.7% | 38.5% | · | · | |
| Operating Margin | -24270.7% | -1148.5% | -905.0% | -224.3% | · | · | |
| Net Margin | -14677.1% | -1169.7% | -879.5% | -221.7% | · | · | |
| Pretax Margin | -14677.1% | -1169.7% | -879.5% | -221.7% | · | · | |
| EBITDA Margin | -22349.8% | -1102.4% | -865.0% | -213.6% | · | · | |
| ROA | -29.1% | -102.2% | · | -29.7% | -37.3% | · | |
| ROE | -586.8% | 358.7% | · | -37.3% | -24.4% | · | |
| ROIC | -137.5% | 6472.1% | · | -19.9% | -26.1% | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.2 | · | 11.5 | 17.4 | · | |
| Quick Ratio | 0.1 | 0.2 | · | 11.0 | 15.9 | · | |
| Debt / Equity | 2.5 | -0.9 | · | 1.0 | · | · | |
| Interest Coverage | -15.6 | -46.7 | -90.9 | -119.0 | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | · | 0.1 | · | · | |
| Receivables Turnover | 0.2 | 2.4 | · | 24.4 | · | · |
Stopy Wzrostu 3
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -97.9% | -9.7% | -57.7% | · | · | · | |
| Revenue CAGR 3Y | -79.9% | · | -11.5% | · | · | · | |
| Revenue CAGR 5Y | -57.9% | · | · | · | · | · |
Wycena (TTM) 4
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $54.2K | $3M | $3M | $7M | $0 | · | |
| Net Income TTM | $-8M | $-30M | $-25M | $-15M | $-13M | · | |
| P/E | -0.1 | -0.6 | -70.0 | -182.4 | -134.5 | · | |
| Earnings Yield | -1094.8% | -173.5% | -1.4% | -0.55% | -0.74% | · |
Rachunek zysków i strat 17
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $151.7K | $6M | $27.0K | $15.6K | $6.5K | $5.1K | $394.8K | $426.4K | $618.9K | $1M | $1M | $853.1K | $622.8K | $41.9K | $1M | $2M | |
| Cost of Revenue | $229.5K | $11.1K | $21.6K | $12.5K | $5.2K | $4.1K | $315.8K | $341.1K | $438.4K | $512.0K | $1M | $678.3K | $502.4K | $29.4K | $1M | $1M | |
| Gross Profit | $-93.9K | $7M | $5.4K | $3.1K | $1.3K | $1.0K | $79.0K | $85.3K | $180.4K | $614.7K | $252.6K | $174.8K | $120.4K | $12.5K | $268.3K | $361.8K | |
| R&D Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $564.4K | $2M | $2M | $3M | $3M | $2M | |
| Operating Expenses | $3M | $3M | $4M | $3M | $3M | $2M | $3M | $4M | $15M | $8M | $11M | $5M | $5M | $5M | $6M | $4M | |
| Operating Income | $-3M | $3M | $-4M | $-3M | $-3M | $-2M | $-3M | $-4M | $-15M | $-7M | $-11M | $-5M | $-5M | $-5M | $-6M | $-4M | |
| Interest Expense | $100.5K | $109.3K | $233.4K | $127.1K | $228.7K | $255.8K | $265.6K | $229.1K | $159.7K | $0 | $-1.4K | $95.5K | $95.5K | $93.4K | $94.5K | $32.2K | |
| Other Non-op | · | · | $0 | $0 | $0 | · | $0 | $0 | $-1M | · | · | $0 | $0 | · | · | · | |
| Pretax Income | $-5M | $4M | · | · | $-2M | $-2M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | · | $330.2K | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $3M | $719.2K | $-5M | $-2M | $-2M | $-3M | $-4M | $-15M | $-7M | $-11M | $-5M | $-4M | $-5M | $-5M | $-4M | |
| EPS (Basic) | $-11.58 | $1.39 | $-1.77 | $-2.02 | $-40.72 | $-11.80 | $-10.47 | $-4.13 | $-16.16 | $-0.20 | $-0.30 | $-0.14 | $-0.12 | $-0.14 | $-0.15 | $-0.11 | |
| EPS (Diluted) | $-11.58 | $1.39 | $-1.77 | $-2.02 | $-40.72 | $-11.80 | $-10.47 | $-4.13 | $-16.16 | $-0.20 | $-0.30 | $-0.14 | $-0.12 | $-0.14 | $-0.15 | $-0.11 | |
| Shares (Basic) | 1,327,966 | 904,312 | -46,618,136 | 2,260,068 | 296,686 | 186,149 | -38,144,933 | 945,585 | 945,585 | 37,223,588 | -71,791,923 | 35,926,921 | 35,910,669 | 35,883,779 | -71,605,400 | 35,835,135 | |
| Shares (Diluted) | 1,327,966 | 904,312 | -46,618,136 | 2,260,068 | 296,686 | 186,149 | -38,144,933 | 945,585 | 945,585 | 37,223,588 | -71,791,923 | 35,926,921 | 35,910,669 | 35,883,779 | -71,605,400 | 35,835,135 | |
| EBITDA | $-3M | $3M | · | $-3M | $-3M | $-2M | · | $-4M | $-15M | $-7M | · | $-5M | $-5M | $-5M | · | $-4M |
Bilans 25
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $741.3K | $1M | $2M | $1M | $2M | $1M | $5M | $998.2K | $1M | $4M | $4M | $11M | $7M | $18M | $22M | $26M | |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | $0 | · | $0 | $10M | $10M | $10M | $0 | |
| Receivables | $18.5K | $74.8K | $32.2K | $30.7K | $21.6K | $87.5K | $582.2K | $651.8K | $655.0K | $903.9K | $2M | $710.1K | $707.2K | $252.7K | $417.7K | $355.6K | |
| Prepaid Expense | $282.5K | $297.8K | $222.2K | $210.7K | $295.5K | $256.3K | $328.2K | $356.2K | $404.9K | $783.4K | $1M | $2M | $1M | $1M | $1M | $2M | |
| Other Current Assets | $97.7K | $119.8K | $77.6K | $250.3K | $141.0K | $443.3K | $113.5K | $88.1K | $164.6K | $187.3K | $230.9K | $174.9K | $327.1K | $317.0K | $196.0K | $205.9K | |
| Current Assets | $1M | $2M | $2M | $2M | $3M | $2M | $6M | $2M | $2M | $6M | $6M | $14M | $20M | $30M | $34M | $29M | |
| PP&E (Net) | $21M | $21M | $21M | $23M | $23M | $23M | $23M | $23M | $23M | $23M | $20M | $15M | $13M | $12M | $11M | $11M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $27M | · | · | · | $23M | · | · | · | $13M | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | |
| Other Non-current Assets | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $28.5K | $56.5K | $137.6K | $211.0K | $253.1K | $333.9K | $419.0K | |
| Total Assets | $27M | $27M | $25M | $25M | $29M | $26M | $30M | $27M | $27M | $30M | $29M | $36M | $39M | $44M | $47M | $51M | |
| Accounts Payable | $11M | $12M | $13M | $19M | $19M | $20M | $22M | $23M | $17M | $10M | $6M | $3M | $2M | $1M | $1M | $1M | |
| Short-term Debt | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | · | · | $0 | · | · | · | · | · | |
| Current Liabilities | $19M | $20M | $21M | $27M | $27M | $27M | $30M | $30M | $23M | $13M | $9M | $5M | $5M | $5M | $3M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.5K | · | $56.7K | |
| Deferred Tax | · | · | $24.9K | · | · | · | $40.9K | · | · | · | $146.9K | · | · | · | $0 | · | |
| Other Non-current Liabilities | · | $692.5K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $19M | $22M | $22M | $28M | $29M | $35M | $37M | $37M | $33M | $22M | $15M | $12M | $11M | $11M | $9M | $9M | |
| Long-term Debt | · | · | $0 | $0 | $367.2K | $8M | $7M | $6M | $10M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | |
| Total Debt | $7M | $7M | · | $7M | $6M | $6M | · | $6M | · | · | · | $117.7K | $97.1K | $68.0K | · | · | |
| Common Stock | $161 | $112 | $328 | $262 | $215 | $4.5K | $111 | $3.8K | $3.8K | $3.8K | $3.6K | $3.6K | $3.6K | $3.6K | $3.6K | $3.6K | |
| Paid-in Capital | · | · | $111M | $107M | $105M | $94M | $94M | $87M | $87M | $87M | $84M | $84M | $83M | $83M | $83M | $83M | |
| Retained Earnings | $-110M | $-105M | $-109M | $-109M | $-105M | $-103M | $-101M | $-97M | $-93M | $-78M | $-71M | $-60M | $-55M | $-51M | $-46M | $-40M | |
| Stockholders' Equity | $7M | $6M | $3M | $-2M | $-52.0K | $-9M | $-7M | $-10M | $-6M | $9M | $13M | $24M | $29M | $33M | $37M | $43M | |
| Liabilities + Equity | $27M | $27M | $25M | $25M | $29M | $26M | $30M | $27M | $27M | $30M | $29M | $36M | $39M | $44M | $47M | $51M |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $127.1K | $142.0K | $156.9K | $173.9K | $291.9K | $419.0K | $682.5K | $128.4K | $129.9K | $243.5K | $274.6K | $277.5K | $284.3K | $298.8K | $261.2K | $164.3K | |
| Stock-based Comp | $1.2K | $10.0K | $9.2K | $205.5K | $278.3K | $275.6K | $292.1K | $232.4K | $239.8K | $244.7K | $261.3K | $219.8K | $263.4K | $259.2K | $286.2K | $302.3K | |
| Other Non-cash | · | · | · | · | · | $-2M | · | · | · | $3M | · | · | · | $874.4K | · | · | |
| Operating Cash Flow | $-4M | $-2M | $-3M | $-3M | $-3M | $-4M | $-3M | $-3M | $-5M | $-4M | $-4M | $-6M | $-9M | $-4M | $-4M | $-2M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $113.4K | $37.1K | $-18.6K | $129.7K | $4M | $630.0K | $2M | $300.4K | $68.7K | $10M | |
| Investing Cash Flow | · | · | $0 | $0 | $0 | · | $-113.4K | $-37.1K | $18.6K | $-129.7K | $-4M | $9M | $-2M | $-300.4K | $-68.7K | $7M | |
| Stock Issued | · | · | $4M | $0 | $1M | $1.7K | $4M | $0 | $0 | $3M | $14.0K | $84 | $7.7K | $1.9K | $5.8K | $1.7K | |
| Net Stock Activity | · | · | · | · | · | $1.7K | · | · | · | $3M | · | · | · | $1.9K | · | · | |
| Financing Cash Flow | $3M | $851.6K | $4M | $2M | $5M | $-53.1K | $7M | $3M | $2M | $4M | $-15.2K | $-8.9K | $7.7K | $1.9K | $-39.8K | $6M | |
| Net Change in Cash | $-487.6K | $-723.6K | $855.6K | $-1M | $1M | $-4M | $4M | $-163.1K | $-3M | $489.0K | $-8M | $4M | $-11M | $-4M | $-4M | $11M | |
| Free Cash Flow | · | · | · | · | · | $-4M | · | · | · | $-4M | · | · | · | $-4M | · | · |
Rentowność 8
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 100.5% | · | 20.0% | 20.0% | 20.0% | · | 20.0% | 29.1% | 54.6% | · | 20.5% | 19.3% | 29.9% | · | 20.0% | |
| Operating Margin | · | 49.8% | · | -21095.3% | -52886.7% | -38811.5% | · | -865.4% | -2445.8% | -665.1% | · | -595.2% | -724.2% | -12798.9% | · | -222.2% | |
| Net Margin | · | · | · | -29183.2% | -29431.0% | -43373.6% | · | -915.1% | -2469.1% | -662.8% | · | -578.9% | -691.1% | -12106.8% | · | -216.4% | |
| Pretax Margin | · | 58.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | 52.0% | · | -21095.3% | -52886.7% | -30538.8% | · | -865.4% | -2445.8% | -643.5% | · | -595.2% | -724.2% | -12085.4% | · | -222.2% | |
| ROA | -18.8% | · | · | -17.5% | -6.9% | -7.8% | · | -12.6% | -46.1% | -20.2% | · | -11.4% | -9.9% | -10.7% | · | -7.3% | |
| ROE | -141.5% | · | · | 75.4% | 60.7% | -2460.8% | · | -56.2% | -137.1% | -36.1% | · | -14.9% | -11.5% | -12.4% | · | -8.1% | |
| ROIC | · | 23.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.5 | · | 2.6 | 4.4 | 6.6 | · | 12.5 | |
| Quick Ratio | 0.0 | 0.1 | · | 0.0 | 0.1 | 0.0 | · | 0.1 | 0.1 | 0.4 | · | 2.2 | 4.0 | 6.3 | · | 11.6 | |
| Debt / Equity | 0.9 | 1.1 | · | -3.2 | -123.6 | -0.7 | · | -0.6 | · | · | · | 0.0 | 0.0 | 0.0 | · | · | |
| Interest Coverage | -31.5 | 29.6 | · | -25.9 | -15.1 | -7.7 | · | -16.5 | -94.8 | · | · | -53.2 | -47.2 | -57.4 | · | · |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.2 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | 80.1 | · | 0.0 | 0.0 | 0.0 | · | 0.6 | 0.9 | 1.9 | · | 1.6 | 1.2 | 0.1 | · | 8.5 |
Wycena (TTM) 4
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $7M | $7M | · | $453.6K | $1M | $2M | · | $3M | $3M | $3M | · | $3M | $3M | $5M | · | $5M | |
| Net Income TTM | $-8M | $-5M | · | $-13M | $-23M | $-29M | · | $-32M | $-32M | $-22M | · | $-18M | $-17M | $-15M | · | $-14M | |
| P/E | -0.1 | -0.0 | · | -0.3 | -0.1 | -0.5 | · | -1.0 | -1.6 | -116.7 | · | -149.0 | -184.7 | -136.7 | · | -223.4 | |
| Earnings Yield | -1060.7% | -14763.9% | · | -351.1% | -684.2% | -182.1% | · | -95.7% | -64.2% | -0.86% | · | -0.67% | -0.54% | -0.73% | · | -0.45% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $54.2K | $3M | $3M | $7M | $0 |
| Marża Brutto % | 20.0% | 37.4% | 19.7% | 38.5% | — |
| Marża Operacyjna % | -24270.7% | -1148.5% | -905.0% | -224.3% | — |
| Zysk netto | $-8M | $-30M | $-25M | $-15M | $-13M |
| Rozwodniony EPS | $-10.63 | $-30.96 | $-0.70 | $-0.42 | $-0.69 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 2.5 | -0.9 | — | 1.0 | — |
| Wskaźnik bieżący | 0.1 | 0.2 | — | 11.5 | 17.4 |
| Wskaźnik Szybkości | 0.1 | 0.2 | — | 11.0 | 15.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-13M | $-14M | $-29M | $-21M | $-11M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 1 emitent · $2K łącznie · Na dzień 31 grudnia 2025
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q1 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 5 (0 vs poprzedni kw.) | 4 (+3 vs poprzedni kw.) | 5 (+3 vs poprzedni kw.) | 0 (-2 vs poprzedni kw.) | +22K |
Porównano z Q4 2025. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $1 848 | 1 903 | 100,00% | Akcje |
Insiderzy spółki 10 insiderów · 5 dyrektorzy generalni · 5 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Hing C. Wong, Ph.D. | Chief Executive Officer | 29 lipca 2026 P | 125 845 | 1 | 0 | $59 882 |
| Rebecca Byam | Chief Financial Officer | 7 maja 2025 P | 43 010 | 0 | 0 | $0 |
| Lee Flowers | SVP of Business Development | 29 lipca 2026 P | 8 691 | 1 | 0 | $19 959 |
| Peter Rhode | Title of the Officer: Chief Scientific Officer and Vice President of Clinical Operations. | 11 grudnia 2023 M | 77 500 | 0 | 0 | $0 |
| Jin-An Jiao | VP of Development | 31 maja 2022 M | 45 141 | 0 | 0 | $0 |
| Scott T Garrett | Dyrektor | 29 lipca 2026 P | 41 644 | 1 | 0 | $19 959 |
| Gary M Winer | Dyrektor | 16 maja 2025 P | 4 075 | 0 | 0 | $0 |
| Rick S. Greene | Dyrektor | 7 maja 2025 P | 2 066 | 0 | 0 | $0 |
| Lisa M. Giles | Dyrektor | 14 czerwca 2024 A | 35 815 | 0 | 0 | $0 |
| Medmira Capital Ltd. | Posiadacz 10% | 15 września 2021 J | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 2 akcje
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Hing C. Wong, Ph.D. ×2 zgłoszenia | 13 czerwca 2025 | 23,38% | Aneks | — | SEC |
| Hing C. Wong (2) | 22 listopada 2024 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2 004 SH | 8 sierpnia 2026 | Dziennie |